The bidirectional relationship between periodontal disease and diabetes mellitus
Main Article Content
Abstract
This study explores the complicated relationships between gum inflammation severity, inflammatory markers (IL-6 and CRP), and fasting blood sugar levels, linking oral and systemic health. A study of mild, severe, and moderate gum inflammation groups found significant differences in IL-6, CRP, and fasting blood sugar. IL-6 levels are much greater in severe gum inflammation, indicating inflammation. Additionally, severe gum inflammation raises CRP, suggesting a systemic inflammatory response to periodontal disease. Fasting blood sugar differs for severe and mild gum inflammation. This disparity indicates glucose metabolism issues and oral-systemic health. Chronic inflammation and reduced insulin sensitivity from severe gum disease increase fasting blood sugar and diabetes risk. These findings emphasize dental-systemic health. Monitor gum inflammation patients' IL-6, CRP, and fasting blood sugar to assess severity and systemic consequences, the study's bidirectional relationship may enhance health outcomes through focused interventions, preventive measures, and collaborative healthcare.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Sedghi, L. M., Bacino, M., & Kapila, Y. L. (2021). Periodontal disease: the good, the bad, and
the unknown. Frontiers in cellular and infection microbiology, 11, 766944.
Deo, P. N., Deshmukh, R. (2019). Oral Microbiome: Unveiling the Fundamentals. J. Oral.
Maxillofac. Pathol.: JOMFP. 23, 122. doi: 10.4103/jomfp.JOMFP_304_18
Aral, K., Milward, M. R., Kapila, Y., Berdeli, A., & Cooper, P. R. (2020). Inflammasomes and
their regulation in periodontal disease: a review. Journal of Periodontal Research, 55(4), 473-
Scannapieco, F. A., & Gershovich, E. (2020). The prevention of periodontal disease—An
overview. Periodontology 2000, 84(1), 9-13.
Madiba, T. K., & Bhayat, A. (2018). Periodontal disease-risk factors and treatment
options. South African dental journal, 73(9), 571-575.
Liccardo, D., Cannavo, A., Spagnuolo, G., Ferrara, N., Cittadini, A., Rengo, C., & Rengo, G.
(2019). Periodontal disease: a risk factor for diabetes and cardiovascular disease. International
journal of molecular sciences, 20(6), 1414.
Cole, J. B., & Florez, J. C. (2020). Genetics of diabetes mellitus and diabetes
complications. Nature reviews nephrology, 16(7), 377-390.
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020). Pancreatic β-cells in type 1 and type 2 diabetes
mellitus: different pathways to failure. Nature Reviews Endocrinology, 16(7), 349-362.
Himanshu, D., Ali, W., & Wamique, M. (2020). Type 2 diabetes mellitus: pathogenesis and
genetic diagnosis. Journal of Diabetes & Metabolic Disorders, 19, 1959-1966.
Cloete, L. (2021). Diabetes mellitus: an overview of the types, symptoms, complications and
management. Nursing Standard (Royal College of Nursing (Great Britain): 1987), 37(1), 61-
Du, Y. T., Rayner, C. K., Jones, K. L., Talley, N. J., & Horowitz, M. (2018). Gastrointestinal
symptoms in diabetes: prevalence, assessment, pathogenesis, and management. Diabetes
care, 41(3), 627-637.
Balaji, R., Duraisamy, R., & Kumar, M. P. (2019). Complications of diabetes mellitus: A
review. Drug Invention Today, 12(1).
Graves, D. T., Ding, Z., & Yang, Y. (2020). The impact of diabetes on periodontal
diseases. Periodontology 2000, 82(1), 214-224.
Rose-John, S. (2018). Interleukin-6 family cytokines. Cold Spring Harbor perspectives in
biology, 10(2), a028415.
Ridker, P. M., & Rane, M. (2021). Interleukin-6 signaling and anti-interleukin-6 therapeutics
in cardiovascular disease. Circulation research, 128(11), 1728-1746.